 after EVAR, particularly among patients of
advanced age, with Medicaid eligibility, or after treatment at a low-volume center.753,755 Although the risks of
late device-related complications and aneurysm rupture
are well documented, population studies have not
demonstrated that annual EVAR surveillance confers a
survival beneÔ¨Åt or decreases aneurysm-related mortality.754,756 Not all late ruptures are preceded by